Telligent Fund’s Boston Scientific BSX Stock Holding History

Telligent Fund’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-12,000	Closed	-$1.17M	–	25
2025 Q3	$1.17M	Buy	+12,000	New	+$1.24M	1%	29

Other funds holding BSX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Telligent Fund's BSX Position: Q4 2025 in Review

Telligent Fund sold out of Boston Scientific (BSX) in Q4 2025, closing a stake of 12,000 shares — an estimated $1.17M sold.

Telligent Fund first reported a position in BSX in Q3 2025 and held it in 1 quarter. The position peaked at $1.17M in Q3 2025. 1,793 funds tracked by Wall St. Rank hold BSX as of Q4 2025.

Telligent Fund reported no remaining Boston Scientific position as of Q4 2025 after selling out during the quarter.
Telligent Fund sold 12,000 Boston Scientific shares in Q4 2025, an estimated $1.17M.
Telligent Fund first reported a position in Boston Scientific in Q3 2025 and held it in 1 quarter.
Telligent Fund's Boston Scientific position peaked at $1.17M in Q3 2025.
1,793 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2025.

Based on Telligent Fund's 13F filing for Q4 2025, filed 10 Feb 2026.